News | December 15, 2022
Briefs: Jubilant Pharmova and Apollo Hospitals Enterprise
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The investment will enable the company to enter European markets as well as enhance margins in current markets
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
The current ruling will assure the safety of the use of Ranitidine for Indian patients
EC grants conditional marketing authorization based on the EFFISAYIL trial
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
The hospital is being developed at a cost of more than Rs. 1,575 crore
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
Company to open new headquarters in 2024
Subscribe To Our Newsletter & Stay Updated
